Stock listing

BOATS:ADCT ADC Therapeutics SA Stock

US listing (BOATS) of ADC Therapeutics SA · home listing NYSE:ADCT

Follow ADC Therapeutics SA into a list and get an email when it puts out news.

Home listing price · NYSE:ADCT

$1.54 USD +0.01 (+0.7%)

Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:ADCT

Past year -63.2% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
$1.50 – $1.68 USDNov 2, 2026
Volume
1.07M sharesNov 2, 2026
Market cap
$196.6M USDAt the close on Nov 2, 2026 · price × 127.7M shares outstanding
52-week range
$0.78 – $4.98 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$1.97M USDMedian day 1.32M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
ADC Therapeutics SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:ADCT · Home$1.54 USD+0.01 (+0.7%)1,071,483$1.58$1.675$1.50$1.53Close on Nov 2, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NYSE:ADCT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.54+0.01+0.7%$1.58$1.675$1.501,071,483
$1.53+0.04+2.7%$1.49$1.54$1.431,175,387
$1.49-0.13-8.0%$1.67$1.70$1.49899,752
$1.62+0.03+1.9%$1.59$1.63$1.545607,765
$1.59+0.08+5.3%$1.49$1.60$1.461,250,598
$1.51+0.07+4.9%$1.45$1.54$1.431,048,540
$1.44-0.16-10.0%$1.58$1.585$1.431,045,600
$1.60+0.10+6.7%$1.50$1.62$1.479824,844
$1.50-0.02-1.3%$1.53$1.555$1.441,328,331
$1.52+0.08+5.6%$1.45$1.55$1.431,057,352
$1.44+0.04+2.9%$1.40$1.49$1.39575,619
$1.40-0.09-6.0%$1.49$1.51$1.40799,525
$1.49+0.04+2.8%$1.47$1.565$1.461,331,061
$1.45-0.25-14.7%$1.67$1.725$1.401,741,916
$1.70-0.16-8.6%$1.86$1.86$1.6253,325,278
$1.86+0.13+7.5%$1.70$1.87$1.641,593,120
$1.73+0.14+8.8%$1.58$1.83$1.563,143,187
$1.59+0.17+12.0%$1.41$1.63$1.325,552,486
$1.42+0.15+11.8%$1.25$1.44$1.2351,750,770
$1.27+0.04+3.3%$1.25$1.27$1.201,352,795
$1.23+0.10+8.8%$1.12$1.26$1.111,752,161
$1.13+0.05+4.6%$1.10$1.14$1.061,320,588
$1.08-0.14-11.5%$1.20$1.201$1.07862,274
$1.22-0.01-0.8%$1.23$1.285$1.201,111,965
$1.23-0.03-2.4%$1.27$1.29$1.20781,015
$1.26-0.01-0.8%$1.24$1.27$1.20835,119
$1.27-0.02-1.6%$1.26$1.285$1.211,076,982
$1.29-0.02-1.5%$1.305$1.31$1.241,575,647
$1.31+0.08+6.5%$1.24$1.32$1.211,972,380
$1.23+0.11+9.8%$1.13$1.25$1.121,674,295
$1.12+0.07+6.7%$1.05$1.13$1.0351,899,275
$1.05-0.01-0.9%$1.06$1.145$1.051,577,209
$1.06+0.01+1.0%$1.06$1.10$1.011,545,569
$1.05-0.04-3.7%$1.09$1.095$1.0253,316,970
$1.09-0.02-1.8%$1.12$1.12$1.031,259,823
$1.11+0.04+3.7%$1.07$1.12$1.06808,479
$1.07-0.04-3.6%$1.13$1.156$1.04989,105
$1.11-0.11-9.0%$1.21$1.24$1.07957,194
$1.22-0.08-6.2%$1.28$1.31$1.1911,709,284
$1.30-0.06-4.4%$1.33$1.35$1.27930,761
$1.36+0.04+3.0%$1.30$1.37$1.301,478,303
$1.320.000.0%$1.32$1.37$1.302,774,762
$1.32+0.08+6.5%$1.23$1.35$1.231,955,644
$1.24+0.07+6.0%$1.15$1.24$1.141,149,641
$1.17+0.03+2.6%$1.13$1.19$1.1251,251,778
$1.14+0.02+1.8%$1.11$1.17$1.072,577,910
$1.12+0.07+6.7%$1.05$1.14$1.051,403,771
$1.05+0.01+1.0%$1.04$1.075$1.011,947,239
$1.04+0.075+7.8%$0.976$1.05$0.963,927,974
$0.965-0.032-3.2%$0.99$1.00$0.951640,512
$0.997+0.037+3.8%$0.974$1.00$0.971,088,237
$0.96-0.08-7.7%$1.02$1.04$0.952,422,878
$1.04+0.01+1.0%$1.05$1.09$1.0151,900,697
$1.03-0.07-6.4%$1.05$1.08$1.033,444,158
$1.10+0.09+8.9%$0.99$1.10$0.953,732,948
$1.01-0.04-3.8%$1.02$1.04$1.001,347,088
$1.05-0.18-14.6%$1.07$1.10$0.9392,190,300
$1.23+0.05+4.2%$1.20$1.23$1.155563,556
$1.18+0.05+4.4%$1.11$1.20$1.11664,343
$1.130.000.0%$1.14$1.17$1.12569,554
$1.130.000.0%$1.08$1.17$1.08534,556
$1.13+0.06+5.6%$1.07$1.13$1.07722,735
$1.07-0.03-2.7%$1.11$1.15$1.07971,135
$1.10+0.05+4.8%$1.05$1.12$1.041,368,010
$1.050.000.0%$1.07$1.08$1.03866,391
Ticker
BOATS:ADCT
Asset type
Stock
Exchange
BOATS
Currency
USD

What changed lately

Calls

Upcoming

  • ADC Therapeutics (NYSE:ADCT) Q3 2026 Earnings Call

    Mon, Nov 09, 2026 · 8:30 AM ET

    Register

Replays

  • ADC Therapeutics (NYSE:ADCT) Q2 2026 Earnings Call

    Thu, Aug 13, 2026 · 8:30 AM ET

    Watch Transcript
  • ADC Therapeutics (NYSE:ADCT) Q1 2026 Earnings Call

    Mon, May 04, 2026 · 8:30 AM ET

    Watch Transcript
  • ADC Therapeutics (NYSE:ADCT) Q4 2025 Earnings Call

    Tue, Mar 10, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

All ADC Therapeutics SA news

Financings

  • Private placement of common shares and pre-funded warrants

    Oct 8, 2026

    Announced: US$86.6M · US$1.42 a share · Jefferies +2

    Dealers: Jefferies, Guggenheim Securities, Cantor

    Buyers: Bain Capital Life Sciences; Redmile; TCGX; Nantahala Capital

    Use of proceeds: Fund ZYNLONTA pipeline studies including Phase 3 trials in DLBCL and MZL, strengthen the balance sheet, working capital and general corporate purposes

    Announced Oct 8, 2026

Read by 6ix AI from the company's releases

Decks

ADC Therapeutics SA on 6ix

News releases
23 in the last 12 months · 41 in all · newest Nov 2, 2026 · oldest 2025
Calls
25 calls with a replay · 25 with a transcript · latest Aug 13, 2026
Decks
36 decks · latest Aug 13, 2026

Where ADC Therapeutics SA is listed

ListingExchangeCountryCurrency
NYSE:ADCT · Home listingNYSEUnited StatesUSD
BOATS:ADCT · This pageBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about ADC Therapeutics SA.